Name: Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [(Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)] & Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: HIT3094
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 MARKET SCOPE 35 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35 1.3.2 INCLUSIONS & EXCLUSIONS 36 1.3.3 YEARS CONSIDERED 37 1.4 CURRENCY CONSIDERED 37 1.5 LIMITATIONS 38 1.6 STAKEHOLDERS 38 1.7 SUMMARY OF CHANGES 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.1.1 SECONDARY DATA 41 2.1.1.1 Key data from secondary sources 41 2.1.2 PRIMARY DATA 42 2.1.2.1 Key data from primary sources 43 2.1.2.2 Breakdown of primary sources 44 2.2 RESEARCH METHODOLOGY DESIGN 45 2.3 MARKET SIZE ESTIMATION 46 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 52 2.5 RESEARCH ASSUMPTIONS 53 2.5.1 MARKET SIZING ASSUMPTIONS 53 2.5.2 OVERALL STUDY ASSUMPTIONS 54 2.6 RISK ASSESSMENT 54 2.7 RESEARCH LIMITATIONS 55 2.7.1 METHODOLOGY-RELATED LIMITATIONS 55 2.7.2 SCOPE-RELATED LIMITATIONS 55 3 EXECUTIVE SUMMARY 56 4 PREMIUM INSIGHTS 62 4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW 62 4.2 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT & REGION 63 4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64 4.4 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES 65 5 MARKET OVERVIEW 66 5.1 INTRODUCTION 66 5.2 MARKET DYNAMICS 66 5.2.1 MARKET DYNAMICS 68 5.2.1.1 Rising burden of chronic and rare diseases 68 5.2.1.2 Shift toward value-based and patient-centered care 68 5.2.1.3 Expansion of real-world evidence (RWE) and post-marketing surveillance needs 69 5.2.1.4 Increasing use of digital health technologies and interoperable EHRs 69 5.2.1.5 Government and regulatory incentives for registry implementation 70 5.2.2 MARKET RESTRAINTS 70 5.2.2.1 Shortage of trained and skilled resources 70 5.2.2.2 High implementation and maintenance costs 71 5.2.3 MARKET OPPORTUNITIES 71 5.2.3.1 Expansion of population health management and outcomes tracking 71 5.2.3.2 Rising demand for pregnancy and congenital anomaly registries for maternal-fetal safety monitoring 72 5.2.3.3 Growing preference for subscription-based deployment models 72 5.2.4 MARKET CHALLENGES 73 5.2.4.1 Privacy- and data security-related concerns 73 5.2.4.2 Reluctance to adopt advanced patient registry solutions 74 5.2.4.3 Limited awareness among healthcare stakeholders 74 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74 5.4 INDUSTRY TRENDS 75 5.4.1 STRENGTHENED FUNDING FOR PATIENT-CENTERED RESEARCH AND RARE DISEASE REGISTRIES 75 5.4.2 RISE IN AUTOMATED DATA ENTRY AND REGISTRY INTELLIGENCE 75 5.4.3 CLOUD-BASED REGISTRIES AND DECENTRALIZED ACCESS 76 5.5 ECOSYSTEM ANALYSIS 77 5.6 VALUE CHAIN ANALYSIS 80 5.7 TECHNOLOGY ANALYSIS 82 5.7.1 KEY TECHNOLOGIES 82 5.7.1.1 Electronic data capture (EDC) systems 82 5.7.1.2 Cloud computing & SaaS architecture 83 5.7.1.3 Data privacy & security technologies 83 5.7.2 COMPLEMENTARY TECHNOLOGIES 84 5.7.2.1 Electronic health record (EHR) systems 84 5.7.2.2 Clinical trial management systems (CTMS) 84 5.7.3 ADJACENT TECHNOLOGIES 84 5.7.3.1 Digital therapeutics (DTx) platforms 84 5.7.3.2 Wearable devices & remote monitoring tools 85 5.7.3.3 Blockchain for health data management 85 5.8 REGULATORY ANALYSIS 86 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 5.8.2 REGULATORY LANDSCAPE 88 5.8.2.1 North America 88 5.8.2.2 Europe 90 5.8.2.3 Asia Pacific 91 5.8.2.4 Middle East & Africa 92 5.8.2.5 Latin America 92 5.9 PRICING ANALYSIS 93 5.9.1 AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (2024) 93 5.9.2 INDICATIVE PRICE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024) 94 5.10 PORTER’S FIVE FORCES ANALYSIS 94 5.10.1 INTENSITY OF COMPETITIVE RIVALRY 95 5.10.2 BARGAINING POWER OF BUYERS 96 5.10.3 THREAT OF SUBSTITUTES 96 5.10.4 THREAT OF NEW ENTRANTS 96 5.10.5 BARGAINING POWER OF SUPPLIERS 96 5.11 PATENT ANALYSIS 96 5.11.1 PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE MARKET 97 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE 97 5.11.3 MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET 98 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 100 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 5.12.2 KEY BUYING CRITERIA 101 5.13 END-USER ANALYSIS 102 5.13.1 UNMET NEEDS 102 5.13.2 END-USER EXPECTATIONS 102 5.14 KEY CONFERENCES & EVENTS, 2025–2026 103 5.15 CASE STUDY ANALYSIS 105 5.16 INVESTMENT & FUNDING SCENARIO 107 5.17 BUSINESS MODEL ANALYSIS 107 5.18 IMPACT OF AI/GEN AI ON PATIENT REGISTRY SOFTWARE MARKET 108 5.18.1 TOP USE CASES & MARKET POTENTIAL 108 5.18.2 KEY USE CASES 110 5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 110 5.18.3.1 Case study: AI-powered data summarization improves registry utilization efficiency 110 5.18.4 ELECTRONIC HEALTH RECORD (EHR) MARKET 112 5.18.5 REAL WORLD EVIDENCE (RWE) MARKET 112 5.18.6 USER READINESS AND IMPACT ASSESSMENT 112 5.18.6.1 User readiness 112 5.18.6.1.1 Hospitals & research networks 112 5.18.6.2 Impact assessment 112 5.18.6.2.1 Hospitals & academic research institutes 112 5.18.6.2.1.1 Implementation 112 5.18.6.2.1.2 Impact 113 5.19 IMPACT OF 2025 US TARIFFS ON PATIENT REGISTRY SOFTWARE MARKET 113 5.19.1 INTRODUCTION 113 5.19.2 KEY TARIFF RATES 114 5.19.3 PRICE IMPACT ANALYSIS 115 5.19.3.1 Cloud hosting infrastructure 115 5.19.3.2 AI & analytics modules 115 5.19.3.3 Offshore development & support services 115 5.19.4 IMPACT ON COUNTRY/REGION 115 5.19.4.1 US 115 5.19.4.2 Europe 115 5.19.4.3 Asia Pacific 115 5.19.5 IMPACT ON END-USE INDUSTRIES 116 5.19.5.1 For-profit registries 116 5.19.5.2 Nonprofit registries 116 5.19.5.3 Government & third-party administrators 117 5.19.5.4 Others 117 6 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE 118 6.1 INTRODUCTION 119 6.2 DISEASE REGISTRIES 119 6.2.1 DIABETES REGISTRIES 121 6.2.1.1 Need to monitor disease prevalence, treatment adherence, and long-term complications to boost adoption 121 6.2.2 CARDIOVASCULAR REGISTRIES 121 6.2.2.1 Ability of cardiovascular registries to enable healthcare systems to benchmark care quality and identify treatment gaps to boost growth 121 6.2.3 CANCER REGISTRIES 122 6.2.3.1 Critical tools for understanding cancer epidemiology and evaluating screening programs to drive market 122 6.2.4 RARE DISEASE REGISTRIES 123 6.2.4.1 Essential tools for advancing knowledge about rare diseases to support market growth 123 6.2.5 ASTHMA REGISTRIES 124 6.2.5.1 Improving asthma management and reducing exacerbations to fuel growth 124 6.2.6 CHRONIC KIDNEY REGISTRIES 125 6.2.6.1 Ability of registries to collect detailed data on disease progression, lab results, and treatment adherence to boost adoption 125 6.2.7 ORTHOPEDIC REGISTRIES 125 6.2.7.1 Ability to monitor implant performance, surgical outcomes, and complication rates to drive growth 125 6.2.8 IMMUNIZATION REGISTRIES 126 6.2.8.1 Strengthening vaccine coverage and safety monitoring to propel market 126 6.2.9 BIRTH DEFECT REGISTRIES 127 6.2.9.1 Need to track and prevent congenital anomalies through birth defect registries to propel market growth 127 6.2.10 OTHER DISEASE REGISTRIES 128 6.3 PRODUCT REGISTRIES 129 6.3.1 MEDICAL DEVICE REGISTRIES 130 6.3.1.1 Ability of these registries to enhance safety, performance monitoring, and regulatory compliance to boost growth 130 6.3.2 DRUG REGISTRIES 131 6.3.2.1 Ability to support long-term safety, real-world evidence, and optimal therapy use to propel growth 131 7 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT 132 7.1 INTRODUCTION 133 7.2 DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES 133 7.2.1 INCREASING PATIENT ENGAGEMENT AND DEMAND FOR SELF-REPORTED DATA TO BOOST MARKET GROWTH 133 7.3 SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES 134 7.3.1 GROWING NEED FOR ACCURATE, CLINICIAN-VERIFIED DATA AND SEAMLESS EHR INTEGRATION TO SUPPORT GROWTH 134 8 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE 136 8.1 INTRODUCTION 137 8.2 MEDICAL RESEARCH & CLINICAL STUDIES 137 8.2.1 GROWING NEED TO LEVERAGE REGISTRIES TO ENHANCE REAL-WORLD EVIDENCE AND CLINICAL TRIAL EFFICIENCY TO FUEL GROWTH 137 8.3 QUALITY IMPROVEMENT 138 8.3.1 ADVANTAGES SUCH AS EVIDENCE-BASED PRACTICE AND PERFORMANCE BENCHMARKING TO DRIVE SEGMENTAL GROWTH 138 8.4 PATIENT CARE MANAGEMENT 139 8.4.1 ABILITY TO EMPOWER PROACTIVE CHRONIC DISEASE MANAGEMENT THROUGH CENTRALIZED REGISTRIES TO SUPPORT GROWTH 139 8.5 POPULATION HEALTH 140 8.5.1 EXPANDING ROLE OF PATIENT MANAGEMENT SYSTEMS IN DRIVING DIGITAL TRANSFORMATION TO CONTRIBUTE TO GROWTH 140 8.6 POINT-OF-CARE SUPPORT 141 8.6.1 NEED FOR PERSONALIZED TREATMENT PLANS AND SHARED DECISION-MAKING TO DRIVE EFFICIENCY AND QUALITY IN HEALTHCARE 141 8.7 PUBLIC HEALTH SURVEILLANCE 142 8.7.1 ABILITY OF REGISTRIES TO ENHANCE PREPAREDNESS AND RESPONSE CAPABILITIES TO DRIVE SEGMENTAL GROWTH 142 8.8 PATIENT SELF-CARE 143 8.8.1 GROWING EMPHASIS ON PATIENT EMPOWERMENT AND SELF-MANAGEMENT TO PROPEL GROWTH 143 8.9 PATIENT ENGAGEMENT 144 8.9.1 ADVANTAGES SUCH AS BETTER DATA ACCURACY AND MORE MEANINGFUL OUTCOMES TO BOOST GROWTH 144 8.10 OTHER USE CASES 145 9 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT 147 9.1 INTRODUCTION 148 9.2 ON-PREMISE MODELS 148 9.2.1 GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE TO DRIVE MARKET GROWTH 148 9.3 CLOUD-BASED MODELS 149 9.3.1 SCALABILITY, INTEROPERABILITY, AND COST-EFFECTIVENESS OF CLOUD-BASED MODELS TO DRIVE GROWTH 149 10 PATIENT REGISTRY SOFTWARE MARKET, BY END USER 151 10.1 INTRODUCTION 152 10.2 FOR-PROFIT REGISTRIES 152 10.2.1 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES 153 10.2.1.1 Need for robust evidence generation, enhanced patient safety, and competitive differentiation to drive adoption 153 10.2.2 HEALTHCARE PAYERS 154 10.2.2.1 Need to improve population health management, control costs, and assess treatment value to drive demand 154 10.2.3 HEALTHCARE PROVIDERS 155 10.2.3.1 Hospitals 156 10.2.3.1.1 Ability of registries to help hospitals collect detailed data on procedures, outcomes, and complications to boost market 156 10.2.3.2 Clinics & outpatient settings 157 10.2.3.2.1 Ability of registries to enable data-driven decision-making and streamlined documentation to drive demand 157 10.2.3.3 Other healthcare providers 158 10.3 NONPROFIT REGISTRIES 159 10.3.1 MEDICAL SPECIALTY SOCIETIES 160 10.3.1.1 Advantages such as defined best practices and improved care delivery to propel growth 160 10.3.2 PATIENT ORGANIZATIONS 161 10.3.2.1 Importance of facilitating clinical trial recruitment and fostering collaboration with researchers to support growth 161 10.4 GOVERNMENT & THIRD-PARTY ADMINISTRATORS 162 10.4.1 ABILITY OF GOVERNMENT-RUN REGISTRIES TO EVALUATE SUCCESS OF HEALTHCARE INITIATIVES TO FUEL MARKET 162 10.5 OTHER END USERS 163 11 PATIENT REGISTRY SOFTWARE MARKET, BY REGION 165 11.1 INTRODUCTION 166 11.2 NORTH AMERICA 166 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 167 11.2.2 US 172 11.2.2.1 US to dominate global market for patient registry software 172 11.2.3 CANADA 177 11.2.3.1 Government investment, collaborative initiatives, and strong push to standardize rare disease registries to drive growth 177 11.3 EUROPE 182 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 183 11.3.2 UK 189 11.3.2.1 Growing incidence of cancer to drive market growth 189 11.3.3 GERMANY 194 11.3.3.1 National rollout of e-patient files and rare disease registries to strengthen patient care and research 194 11.3.4 FRANCE 198 11.3.4.1 Growing patient registry adoption with national data platforms and rare disease initiatives to support market growth 198 11.3.5 ITALY 203 11.3.5.1 Growing number of national networks and disease-specific registries to drive growth 203 11.3.6 SPAIN 207 11.3.6.1 Growing need to address rising chronic and cardiovascular disease prevalence to drive adoption 207 11.3.7 REST OF EUROPE 212 11.4 ASIA PACIFIC 216 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 216 11.4.2 JAPAN 223 11.4.2.1 Japan’s aging population and advanced digital strategies to drive growth in patient registry software market 223 11.4.3 CHINA 228 11.4.3.1 Robust national registries and expanding pharmaceutical approvals to drive patient registry software market 228 11.4.4 INDIA 233 11.4.4.1 Digital health advances to boost India’s patient registry software market 233 11.4.5 REST OF ASIA PACIFIC 238 11.5 LATIN AMERICA 243 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 243 11.5.2 BRAZIL 249 11.5.2.1 Brazil to dominate patient registry software market in Latin America 249 11.5.3 MEXICO 254 11.5.3.1 Increase in focus of digital health to boost market growth 254 11.5.4 REST OF LATIN AMERICA 259 11.6 MIDDLE EAST & AFRICA 264 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 264 11.6.2 GCC COUNTRIES 270 11.6.2.1 Rising healthcare investments to fuel uptake 270 11.6.3 REST OF MIDDLE EAST & AFRICA 275 12 COMPETITIVE LANDSCAPE 281 12.1 OVERVIEW 281 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 281 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET 281 12.3 REVENUE ANALYSIS, 2020–2024 283 12.4 MARKET SHARE ANALYSIS, 2024 284 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 287 12.5.1 STARS 287 12.5.2 EMERGING LEADERS 287 12.5.3 PERVASIVE PLAYERS 287 12.5.4 PARTICIPANTS 287 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 289 12.5.5.1 Company footprint 289 12.5.5.2 Region footprint 290 12.5.5.3 Product footprint 291 12.5.5.4 Use case footprint 292 12.5.5.5 Registry type footprint 293 12.5.5.6 Deployment footprint 294 12.5.5.7 End-user footprint 295 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 296 12.6.1 PROGRESSIVE COMPANIES 296 12.6.2 RESPONSIVE COMPANIES 296 12.6.3 DYNAMIC COMPANIES 296 12.6.4 STARTING BLOCKS 296 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 298 12.6.5.1 Detailed list of key startups/SMEs 298 12.6.5.2 Competitive benchmarking of startups/Smes 298 12.7 COMPANY VALUATION & FINANCIAL METRICS 299 12.7.1 FINANCIAL METRICS 299 12.7.2 COMPANY VALUATION 299 12.8 BRAND/SOFTWARE COMPARISON 300 12.9 COMPETITIVE SCENARIO 301 12.9.1 PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS 301 12.9.2 DEALS 302 12.9.3 OTHER DEVELOPMENTS 303 13 COMPANY PROFILES 304 13.1 KEY PLAYERS 304 13.1.1 IBM 304 13.1.1.1 Business overview 304 13.1.1.2 Products offered 305 13.1.1.3 Recent developments 306 13.1.1.3.1 Product enhancements 306 13.1.1.4 MnM view 306 13.1.1.4.1 Right to win 306 13.1.1.4.2 Strategic choices 306 13.1.1.4.3 Weaknesses & competitive threats 307 13.1.2 IQVIA HOLDINGS INC. 308 13.1.2.1 Business overview 308 13.1.2.2 Products offered 309 13.1.2.3 Recent developments 310 13.1.2.3.1 Deals 310 13.1.2.4 MnM view 310 13.1.2.4.1 Right to win 310 13.1.2.4.2 Strategic choices 311 13.1.2.4.3 Weaknesses & competitive threats 311 13.1.3 HEALTH CATALYST, INC. 312 13.1.3.1 Business overview 312 13.1.3.2 Products offered 313 13.1.3.3 Recent developments 314 13.1.3.3.1 Product approvals 314 13.1.3.3.2 Deals 314 13.1.3.3.3 Other developments 315 13.1.3.4 MnM view 315 13.1.3.4.1 Right to win 315 13.1.3.4.2 Strategic choices 315 13.1.3.4.3 Weaknesses & competitive threats 316 13.1.4 ORACLE 317 13.1.4.1 Business overview 317 13.1.4.2 Products offered 319 13.1.4.3 Recent developments 319 13.1.4.3.1 Deals 319 13.1.4.4 MnM view 319 13.1.4.4.1 Right to win 319 13.1.4.4.2 Strategic choices 320 13.1.4.4.3 Weaknesses & competitive threats 320 13.1.5 UNITEDHEALTH GROUP 321 13.1.5.1 Business overview 321 13.1.5.2 Products offered 322 13.1.5.3 Recent developments 323 13.1.5.3.1 Deals 323 13.1.5.4 MnM view 323 13.1.5.4.1 Right to win 323 13.1.5.4.2 Strategic choices 323 13.1.5.4.3 Weaknesses & competitive threats 323 13.1.6 CONDUENT INCORPORATED 324 13.1.6.1 Business overview 324 13.1.6.2 Products offered 326 13.1.6.3 Recent developments 326 13.1.6.3.1 Deals 326 13.1.7 ELEKTA 328 13.1.7.1 Business overview 328 13.1.7.2 Products offered 329 13.1.7.3 Recent developments 330 13.1.7.3.1 Deals 330 13.1.8 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED) 331 13.1.8.1 Business overview 331 13.1.8.2 Products offered 333 13.1.9 DASSAULT SYSTÈMES (MEDIDATA) 334 13.1.9.1 Business overview 334 13.1.9.2 Products offered 336 13.1.9.3 Recent developments 336 13.1.9.3.1 Product launches 336 13.1.9.3.2 Deals 337 13.1.10 EVIDENTIQ (DACIMA SOFTWARE INC.) 338 13.1.10.1 Business overview 338 13.1.10.2 Products offered 338 13.1.10.3 Recent developments 339 13.1.10.3.1 DEALS 339 13.1.11 MRO (FIGMD, INC.) 340 13.1.11.1 Business overview 340 13.1.11.2 Products offered 341 13.1.11.3 Recent developments 342 13.1.11.3.1 Deals 342 13.1.11.3.2 Other developments 342 13.1.12 IMAGETREND 343 13.1.12.1 Business overview 343 13.1.12.2 Products offered 343 13.1.12.3 Recent developments 344 13.1.12.3.1 Product upgrades 344 13.1.12.3.2 Deals 344 13.1.13 GLOBAL VISION TECHNOLOGIES, INC. 346 13.1.13.1 Business overview 346 13.1.13.2 Products offered 346 13.1.13.3 Recent developments 347 13.1.13.3.1 Other developments 347 13.1.14 SYNEOS HEALTH 348 13.1.14.1 Business overview 348 13.1.14.2 Products offered 349 13.1.14.3 Recent developments 350 13.1.14.3.1 Deals 350 13.1.15 VERADIGM LLC 351 13.1.15.1 Business overview 351 13.1.15.2 Products offered 352 13.1.15.3 Recent developments 354 13.1.15.3.1 Product launches 354 13.1.15.3.2 Deals 355 13.1.16 ESO 356 13.1.16.1 Business overview 356 13.1.16.2 Products offered 356 13.1.16.3 Recent developments 357 13.1.16.3.1 Deals 357 13.1.17 ORDINAL DATA INC. 358 13.1.17.1 Business overview 358 13.1.17.2 Products offered 358 13.1.18 CEDARON MEDICAL 360 13.1.18.1 Business overview 360 13.1.18.2 Products offered 360 13.1.19 FIVOS HEALTH 362 13.1.19.1 Business overview 362 13.1.19.2 Products offered 363 13.1.19.3 Recent developments 364 13.1.19.3.1 Deals 364 13.1.20 ACROSS HEALTHCARE 365 13.1.20.1 Business overview 365 13.1.20.2 Products offered 365 13.1.20.3 Recent developments 366 13.1.20.3.1 Deals 366 13.2 OTHER PLAYERS 367 13.2.1 VERANA HEALTH 367 13.2.2 PULSE INFOFRAME INC. 368 13.2.3 AMPLITUDE CLINICAL OUTCOMES 369 13.2.4 NPHASE, INC. (REDCAP CLOUD) 370 13.2.5 OM1 371 14 APPENDIX 372 14.1 DISCUSSION GUIDE 372 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 377 14.3 CUSTOMIZATION OPTIONS 379 14.4 RELATED REPORTS 379 14.5 AUTHOR DETAILS 380

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38 TABLE 2 FACTOR ANALYSIS 50 TABLE 3 RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET 54 TABLE 4 PATIENT REGISTRY SOFTWARE MARKET: IMPACT ANALYSIS 67 TABLE 5 HEALTHCARE DATA BREACHES IN US 73 TABLE 6 PATIENT REGISTRY SOFTWARE MARKET: ROLE IN ECOSYSTEM 79 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA 88 TABLE 13 REGULATORY SCENARIO OF EUROPE 90 TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC 91 TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 92 TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA 92 TABLE 17 AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (ORDINAL HEALTH INC.) (2024) 93 TABLE 18 INDICATIVE PRICE RANGE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024) 94 TABLE 19 PATIENT REGISTRY SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 95 TABLE 20 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE 98 TABLE 21 PATIENT REGISTRY SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 99 TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 100 TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 101 TABLE 24 UNMET NEEDS IN PATIENT REGISTRY SOFTWARE MARKET 102 TABLE 25 END-USER EXPECTATIONS IN PATIENT REGISTRY SOFTWARE MARKET 103 TABLE 26 PATIENT REGISTRY SOFTWARE MARKET: KEY CONFERENCES & EVENTS, 2025–2026 104 TABLE 27 CASE STUDY 1: CANCER REGISTRY IMPLEMENTATION WITH DACIMA CLINICAL SUITE 105 TABLE 28 CASE STUDY 2: ENHANCING REAL-WORLD EVIDENCE WITH CASTOR RWE 106 TABLE 29 CASE STUDY 3: DEVICE DATA INTEGRATION USING MEDIREPORT 360 106 TABLE 30 US-ADJUSTED RECIPROCAL TARIFF RATES 114 TABLE 31 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 119 TABLE 32 PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 33 PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 34 PATIENT REGISTRY SOFTWARE MARKET FOR DIABETES REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 35 PATIENT REGISTRY SOFTWARE MARKET FOR CARDIOVASCULAR REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 36 PATIENT REGISTRY SOFTWARE MARKET FOR CANCER REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 37 PATIENT REGISTRY SOFTWARE MARKET FOR RARE DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 38 PATIENT REGISTRY SOFTWARE MARKET FOR ASTHMA REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 39 PATIENT REGISTRY SOFTWARE MARKET FOR CHRONIC KIDNEY REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 40 PATIENT REGISTRY SOFTWARE MARKET FOR ORTHOPEDIC REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 41 PATIENT REGISTRY SOFTWARE MARKET FOR IMMUNIZATION REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 42 PATIENT REGISTRY SOFTWARE MARKET FOR BIRTH DEFECT REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 43 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER DISEASE REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 44 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 45 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 46 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL DEVICE REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 47 PATIENT REGISTRY SOFTWARE MARKET FOR DRUG REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 48 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 133 TABLE 49 PATIENT REGISTRY SOFTWARE MARKET FOR DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 51 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 137 TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR QUALITY IMPROVEMENT, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 55 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR POINT-OF-CARE SUPPORT, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC HEALTH SURVEILLANCE, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 58 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT SELF-CARE, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER USE CASES, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 61 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 148 TABLE 62 PATIENT REGISTRY SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 63 PATIENT REGISTRY SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 64 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 65 PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 66 PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 67 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 68 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 69 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 70 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 71 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 72 PATIENT REGISTRY SOFTWARE MARKET FOR CLINICS & OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 73 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 74 PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 75 PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 76 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL SPECIALTY SOCIETIES, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 77 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 78 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT & THIRD-PARTY ADMINISTRATORS, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 79 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 80 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 81 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 82 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 83 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 169 TABLE 84 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 169 TABLE 85 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 86 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 87 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 171 TABLE 88 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 89 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 90 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 91 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 92 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 93 US: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 174 TABLE 94 US: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 174 TABLE 95 US: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 96 US: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 97 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 176 TABLE 98 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 99 US: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 100 US: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 101 US: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 102 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 103 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 179 TABLE 104 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 179 TABLE 105 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 106 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 107 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 181 TABLE 108 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 181 TABLE 109 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 110 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 111 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 112 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 113 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 114 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 186 TABLE 115 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 186 TABLE 116 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 117 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 118 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 188 TABLE 119 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 188 TABLE 120 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 121 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 122 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 123 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 124 UK: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 190 TABLE 125 UK: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 191 TABLE 126 UK: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 127 UK: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 128 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 192 TABLE 129 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 130 UK: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 131 UK: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 132 UK: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 133 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 194 TABLE 134 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 195 TABLE 135 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 195 TABLE 136 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 137 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 138 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 197 TABLE 139 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 140 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 141 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 142 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 143 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 144 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 199 TABLE 145 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 200 TABLE 146 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 147 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 148 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 201 TABLE 149 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 150 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 151 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 152 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 153 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 203 TABLE 154 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 204 TABLE 155 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 204 TABLE 156 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 157 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 158 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 206 TABLE 159 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 160 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 161 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 162 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 163 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 208 TABLE 164 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 208 TABLE 165 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 209 TABLE 166 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 167 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 168 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 210 TABLE 169 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 170 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 171 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 172 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 173 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 212 TABLE 174 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 213 TABLE 175 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 213 TABLE 176 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 177 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 178 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 215 TABLE 179 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 180 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 181 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 182 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 183 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 184 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 218 TABLE 185 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 219 TABLE 186 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 219 TABLE 187 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 188 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 189 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 221 TABLE 190 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 191 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 192 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 193 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 194 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 223 TABLE 195 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 224 TABLE 196 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 224 TABLE 197 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 198 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 199 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 226 TABLE 200 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 201 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 202 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 203 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 204 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 229 TABLE 205 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 229 TABLE 206 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 230 TABLE 207 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 208 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 209 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 231 TABLE 210 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 231 TABLE 211 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 212 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 213 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 214 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 234 TABLE 215 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 234 TABLE 216 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 235 TABLE 217 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 218 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 219 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 236 TABLE 220 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 221 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 222 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 223 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 224 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 239 TABLE 225 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 239 TABLE 226 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 240 TABLE 227 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 228 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 229 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 241 TABLE 230 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 241 TABLE 231 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 232 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 233 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 234 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 235 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 244 TABLE 236 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 245 TABLE 237 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 245 TABLE 238 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 239 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 240 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 247 TABLE 241 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 247 TABLE 242 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 243 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 244 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 245 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 249 TABLE 246 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 250 TABLE 247 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 250 TABLE 248 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 249 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 250 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 252 TABLE 251 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 252 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 253 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 254 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 255 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 254 TABLE 256 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 255 TABLE 257 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 255 TABLE 258 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 259 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 260 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 257 TABLE 261 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 262 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 263 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 264 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 265 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 259 TABLE 266 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 260 TABLE 267 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 260 TABLE 268 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 269 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 270 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 262 TABLE 271 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 272 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 273 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 274 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 275 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 265 TABLE 276 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 265 TABLE 277 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 266 TABLE 278 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 266 TABLE 279 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 280 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 281 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 268 TABLE 282 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 268 TABLE 283 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 284 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 285 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 286 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 271 TABLE 287 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 271 TABLE 288 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 272 TABLE 289 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 290 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 291 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 273 TABLE 292 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 293 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 294 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 295 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 296 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 275 TABLE 297 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023–2030 (USD MILLION) 276 TABLE 298 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023–2030 (USD MILLION) 276 TABLE 299 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 300 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 301 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 278 TABLE 302 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 303 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 304 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 305 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 306 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, JANUARY 2022–JUNE 2025 281 TABLE 307 PATIENT REGISTRY SOFTWARE MARKET: DEGREE OF COMPETITION 285 TABLE 308 PATIENT REGISTRY SOFTWARE MARKET: REGION FOOTPRINT 290 TABLE 309 PATIENT REGISTRY SOFTWARE MARKET: PRODUCT FOOTPRINT 291 TABLE 310 PATIENT REGISTRY SOFTWARE MARKET: USE CASE FOOTPRINT 292 TABLE 311 PATIENT REGISTRY SOFTWARE MARKET: REGISTRY TYPE FOOTPRINT 293 TABLE 312 PATIENT REGISTRY SOFTWARE MARKET: DEPLOYMENT FOOTPRINT 294 TABLE 313 PATIENT REGISTRY SOFTWARE MARKET: END-USER FOOTPRINT 295 TABLE 314 PATIENT REGISTRY SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 298 TABLE 315 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT AND REGION 298 TABLE 316 PATIENT REGISTRY SOFTWARE MARKET: PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025 301 TABLE 317 PATIENT REGISTRY SOFTWARE MARKET: DEALS, JANUARY 2022–JUNE 2025 302 TABLE 318 PATIENT REGISTRY SOFTWARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 303 TABLE 319 IBM: COMPANY OVERVIEW 304 TABLE 320 IBM: PRODUCTS OFFERED 305 TABLE 321 IBM: PRODUCT ENHANCEMENTS, JANUARY 2022–JUNE 2025 306 TABLE 322 IQVIA HOLDINGS INC.: COMPANY OVERVIEW 308 TABLE 323 IQVIA HOLDINGS INC.: PRODUCTS OFFERED 309 TABLE 324 IQVIA HOLDINGS INC.: DEALS, JANUARY 2022–JUNE 2025 310 TABLE 325 HEALTH CATALYST, INC.: COMPANY OVERVIEW 312 TABLE 326 HEALTH CATALYST, INC.: PRODUCTS OFFERED 313 TABLE 327 HEALTH CATALYST, INC.: PRODUCT APPROVALS, JANUARY 2022–JUNE 2025 314 TABLE 328 HEALTH CATALYST, INC.: DEALS, JANUARY 2022–JUNE 2025 314 TABLE 329 HEALTH CATALYST, INC.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 315 TABLE 330 ORACLE: COMPANY OVERVIEW 317 TABLE 331 ORACLE: PRODUCTS OFFERED 319 TABLE 332 ORACLE: DEALS, JANUARY 2022–JUNE 2025 319 TABLE 333 UNITEDHEALTH GROUP: COMPANY OVERVIEW 321 TABLE 334 UNITEDHEALTH GROUP: PRODUCTS OFFERED 322 TABLE 335 UNITEDHEALTH GROUP: DEALS, JANUARY 2022–JUNE 2025 323 TABLE 336 CONDUENT INCORPORATED: COMPANY OVERVIEW 324 TABLE 337 CONDUENT INCORPORATED: PRODUCTS OFFERED 326 TABLE 338 CONDUENT INCORPORATED: DEALS, JANUARY 2022–JUNE 2025 326 TABLE 339 ELEKTA: COMPANY OVERVIEW 328 TABLE 340 ELEKTA: PRODUCTS OFFERED 329 TABLE 341 ELEKTA: DEALS, JANUARY 2022–JUNE 2025 330 TABLE 342 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY OVERVIEW 331 TABLE 343 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): PRODUCTS OFFERED 333 TABLE 344 DASSAULT SYSTÈMES (MEDIDATA): COMPANY OVERVIEW 334 TABLE 345 DASSAULT SYSTÈMES (MEDIDATA): PRODUCTS OFFERED 336 TABLE 346 DASSAULT SYSTÈMES (MEDIDATA): PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 336 TABLE 347 DASSAULT SYSTÈMES (MEDIDATA): DEALS, JANUARY 2022–JUNE 2025 337 TABLE 348 EVIDENTIQ (DECIMA SOFTWARE INC.): COMPANY OVERVIEW 338 TABLE 349 EVIDENTIQ (DECIMA SOFTWARE INC.): PRODUCTS OFFERED 338 TABLE 350 EVIDENTIQ (DECIMA SOFTWARE INC.): DEALS, JANUARY 2022–JUNE 2025 339 TABLE 351 MRO (FIGMD, INC.): COMPANY OVERVIEW 340 TABLE 352 MRO (FIGMD, INC.): PRODUCTS OFFERED 341 TABLE 353 MRO (FIGMD, INC.): DEALS, JANUARY 2022–JUNE 2025 342 TABLE 354 MRO (FIGMD, INC.): OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 342 TABLE 355 IMAGETREND: COMPANY OVERVIEW 343 TABLE 356 IMAGETREND: PRODUCTS OFFERED 343 TABLE 357 IMAGETREND: PRODUCT UPGRADES, JANUARY 2022–JUNE 2025 344 TABLE 358 IMAGETREND: DEALS, JANUARY 2022–JUNE 2025 344 TABLE 359 GLOBAL VISION TECHNOLOGIES, INC.: COMPANY OVERVIEW 346 TABLE 360 GLOBAL VISION TECHNOLOGIES, INC.: PRODUCTS OFFERED 346 TABLE 361 GLOBAL VISION TECHNOLOGIES, INC.: OTHER DEVELOPMENTS , JANUARY 2022–JUNE 2025 347 TABLE 362 SYNEOS HEALTH: COMPANY OVERVIEW 348 TABLE 363 SYNEOS HEALTH: PRODUCTS OFFERED 349 TABLE 364 SYNEOS HEALTH: DEALS, JANUARY 2022–JUNE 2025 350 TABLE 365 VERADIGM LLC: COMPANY OVERVIEW 351 TABLE 366 VERADIGM LLC: PRODUCTS OFFERED 352 TABLE 367 VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 354 TABLE 368 VERADIGM LLC: DEALS, JANUARY 2022–JUNE 2025 355 TABLE 369 ESO: COMPANY OVERVIEW 356 TABLE 370 ESO: PRODUCTS OFFERED 356 TABLE 371 ESO: DEALS, JANUARY 2022–JUNE 2025 357 TABLE 372 ORDINAL DATA, INC.: COMPANY OVERVIEW 358 TABLE 373 ORDINAL DATA, INC.: PRODUCTS OFFERED 358 TABLE 374 CEDARON MEDICAL: COMPANY OVERVIEW 360 TABLE 375 CEDARON MEDICAL: PRODUCTS OFFERED 360 TABLE 376 FIVOS HEALTH: COMPANY OVERVIEW 362 TABLE 377 FIVOS HEALTH: PRODUCTS OFFERED 363 TABLE 378 FIVOS HEALTH: DEALS, JANUARY 2022–JUNE 2025 364 TABLE 379 ACROSS HEALTHCARE: COMPANY OVERVIEW 365 TABLE 380 ACROSS HEALTHCARE: PRODUCTS OFFERED 365 TABLE 381 ACROSS HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 366 FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION & REGIONAL SCOPE 35 FIGURE 2 RESEARCH DESIGN 40 FIGURE 3 PRIMARY SOURCES 42 FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 44 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 44 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 45 FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION 47 FIGURE 8 PATIENT REGISTRY SOFTWARE MARKET: REVENUE ESTIMATION APPROACH 47 FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT REGISTRY SOFTWARE 49 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 51 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51 FIGURE 12 TOP-DOWN APPROACH 52 FIGURE 13 DATA TRIANGULATION METHODOLOGY 53 FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 57 FIGURE 15 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2025 VS. 2030 (USD MILLION) 58 FIGURE 16 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2025 VS. 2030 (USD MILLION) 59 FIGURE 17 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2025 VS. 2030 (USD MILLION) 59 FIGURE 18 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 60 FIGURE 19 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT 61 FIGURE 20 GROWING DEMAND FOR REAL-WORLD EVIDENCE, INTEROPERABILITY, AND REGULATORY COMPLIANCE TO DRIVE MARKET GROWTH 62 FIGURE 21 SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 63 FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64 FIGURE 23 GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED ECONOMIES DURING FORECAST PERIOD 65 FIGURE 24 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66 FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 75 FIGURE 26 PATIENT REGISTRY SOFTWARE MARKET: ECOSYSTEM ANALYSIS 78 FIGURE 27 PATIENT REGISTRY SOFTWARE MARKET: VALUE CHAIN ANALYSIS 80 FIGURE 28 PATIENT REGISTRY SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 95 FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN PATIENT REGISTRY SOFTWARE, 2015–2025 97 FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “PATIENT REGISTRY SOFTWARE” PATENTS (JANUARY 2015–JUNE 2025) 97 FIGURE 31 MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET (JANUARY 2015–JUNE 2025) 98 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 100 FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 101 FIGURE 35 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING PATIENT REGISTRY SOFTWARE ACROSS INDUSTRIES 109 FIGURE 36 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 111 FIGURE 37 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT 167 FIGURE 38 EUROPE: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT 184 FIGURE 39 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT 217 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, 2020–2024 (USD MILLION) 284 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET (2024) 285 FIGURE 42 PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 288 FIGURE 43 PATIENT REGISTRY SOFTWARE MARKET: COMPANY FOOTPRINT 289 FIGURE 44 PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 297 FIGURE 45 EV/EBITDA OF KEY VENDORS 299 FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 299 FIGURE 47 PATIENT REGISTRY SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 300 FIGURE 48 IBM: COMPANY SNAPSHOT (2024) 305 FIGURE 49 IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2024) 309 FIGURE 50 HEALTH CATALYST, INC.: COMPANY SNAPSHOT (2024) 313 FIGURE 51 ORACLE: COMPANY SNAPSHOT (2024) 318 FIGURE 52 UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2024) 322 FIGURE 53 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2024) 325 FIGURE 54 ELEKTA: COMPANY SNAPSHOT (2024) 329 FIGURE 55 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY SNAPSHOT 332 FIGURE 56 DASSAULT SYSTÈMES (MEDIDATA): COMPANY SNAPSHOT (2024) 335 FIGURE 57 VERADIGM LLC: COMPANY SNAPSHOT (2022) 352

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [(Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)] & Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療與生命科學）